Wilson Eduardo Furlan Matos Alves

1PUBLICATIONS

0CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 05, 2019

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.

Wilson Eduardo Furlan Matos Alves, Murilo Bonatelli, Rozany Dufloth

Pageof 1

Frequent Collaborators

Frequent Collaborators